Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Carvedilol products are in shortage in Canada (8 of 30 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
A beta blocker used to treat heart failure and lower blood pressure.
Products affected
8 / 30
In shortage since
Jan 9, 2024
Est. full return
Jul 31, 2026
Reports on file
73
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP-CARVEDILOL
3.125MG · TABLET · JAMP PHARMA CORPORATION
DIN 02368897 · since May 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-CARVEDILOL
3.125MG · TABLET · TEVA CANADA LIMITED
DIN 02252309 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CARVEDILOL
6.25MG · TABLET · TEVA CANADA LIMITED
DIN 02252317 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CARVEDILOL
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02252325 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
12.5MG · TABLET · APOTEX INC
DIN 02247935 · since Jun 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
3.125MG · TABLET · APOTEX INC
DIN 02247933 · since Dec 13, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
6.25MG · TABLET · APOTEX INC
DIN 02247934 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
25MG · TABLET · APOTEX INC
DIN 02247936 · since Jan 9, 2024, no end estimate · Disruption of the manufacture of the drug.
Anticipated
CARVEDILOL
6.25MG · TABLET · SANIS HEALTH INC
DIN 02364921 · Disruption of the manufacture of the drug.
Resolved
JAMP-CARVEDILOL
6.25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02368900 · ended Mar 27, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CARVEDILOL
25MG · TABLET · TEVA CANADA LIMITED
DIN 02252333 · ended Oct 1, 2025 · Disruption of the manufacture of the drug.
Resolved
CARVEDILOL
3.125MG · TABLET · SANIS HEALTH INC
DIN 02364913 · ended Nov 25, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Carvedilol is currently affected by 8 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Carvedilol is classified under “BETA BLOCKING AGENTS” (ATC C07AG).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jul 24, 2026 → Jul 31, 2026
Common questions
What is Carvedilol used for?
A beta blocker used to treat heart failure and lower blood pressure.
When will Carvedilol be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Carvedilol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.